PAMP
CERO

Polar Asset Management Partners’s CERo Therapeutics CERO Stock Holding History

Polar Asset Management Partners’s Portfolio CERO Stock Details CERO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-60
Closed -$1.29M – 987
2023
Q2 		$1.29M Hold
60
– – 0.02% 489
2023
Q1 		$1.28M Sell
60
-240
-80% -$5.06M 0.02% 550
2022
Q4 		$6.16M Hold
300
– – 0.08% 365
2022
Q3 		$6.05M Hold
300
– – 0.07% 405
2022
Q2 		$6.01M Hold
300
– – 0.07% 403
2022
Q1 		$6M Hold
300
– – 0.06% 361
2021
Q4 		$5.95M Buy
+300
New +$5.96M 0.06% 357

Other funds holding CERO

MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $871M AUM 8.61% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

Polar Asset Management Partners's CERO Position: Q3 2023 in Review

Polar Asset Management Partners sold out of CERo Therapeutics (CERO) in Q3 2023, closing a stake of 60 shares — an estimated $1.29M sold.

Polar Asset Management Partners first reported a position in CERO in Q4 2021 and held it in 7 quarters. The position peaked at $6.16M in Q4 2022. 10 funds tracked by Wall St. Rank hold CERO as of Q3 2023.

  • Polar Asset Management Partners reported no remaining CERo Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Polar Asset Management Partners sold 60 CERo Therapeutics shares in Q3 2023, an estimated $1.29M.
  • Polar Asset Management Partners first reported a position in CERo Therapeutics in Q4 2021 and held it in 7 quarters.
  • Polar Asset Management Partners's CERo Therapeutics position peaked at $6.16M in Q4 2022.
  • 10 funds tracked by Wall St. Rank held CERo Therapeutics as of Q3 2023.

Based on Polar Asset Management Partners's 13F filing for Q3 2023, filed 14 Nov 2023.